A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial

A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial

Item
http://www.wikidata.org/entity/Q34747013
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and InflammationAn Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers.IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer.Differential Serum Cytokine Levels and Risk of Lung Cancer Between African and European Americans.The hallmarks of premalignant conditions: a molecular basis for cancer preventionIL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway.Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma.Integration of multiple "OMIC" biomarkers: A precision medicine strategy for lung cancer.Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.Interleukin-6 blockade attenuates lung cancer tissue construction integrated by cancer stem cells.Advances in Proteomic Techniques for Cytokine Analysis: Focus on Melanoma Research.Blood-based biomarkers for precision medicine in lung cancer: precision radiation therapy.Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune MarkersSex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer
P2860

A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial

Item
http://www.wikidata.org/entity/Q34747013
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A combined prognostic serum in ...... ovarian cancer screening trial
@ast
A combined prognostic serum in ...... ovarian cancer screening trial
@en
A combined prognostic serum in ...... ovarian cancer screening trial
@nl
type
label
A combined prognostic serum in ...... ovarian cancer screening trial
@ast
A combined prognostic serum in ...... ovarian cancer screening trial
@en
A combined prognostic serum in ...... ovarian cancer screening trial
@nl
prefLabel
A combined prognostic serum in ...... ovarian cancer screening trial
@ast
A combined prognostic serum in ...... ovarian cancer screening trial
@en
A combined prognostic serum in ...... ovarian cancer screening trial
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
A combined prognostic serum in ...... ovarian cancer screening trial
@en
P2093
P2860
P304
P31
P356
10.1097/JTO.0000000000000278
P433
P478
P50
P577
P698
P921
P932